Olin Biomedical announced that the oral recombinant Helicobacter pylori vaccine (Escherichia coli) has obtained Phase I clinical trial permission in Australia.
欧林生物：口服重组幽门螺杆菌疫苗(大肠杆菌)在澳大利亚获得Ⅰ期临床试验许可
Olin Biomedical: The oral recombinant Helicobacter pylori vaccine (Escherichia coli) has obtained Phase I clinical trial permission in Australia.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.